Navigation Links
ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb
Date:10/30/2010

luded as well as interim SVR rates based on data available to date; and (v) the beneficial effect of ANA598 in both CC and non-CC patients based on observations in the Phase II combination study. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. For example, the results of preclinical and early clinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 or ANA773 will not have unforeseen safety issues, will have favorable results in future clinical trials or will receive regulatory approval. In addition, Anadys' results may be affected by competition from other biotechnology and pharmaceutical companies, its effectiveness at managing its financial resources, its ability to enter into transactions around its product candidates, its ability to successfully develop and market products, difficulties or delays in its preclinical studies or clinical trials, difficulties or delays in manufacturing its clinical trials materials, the scope and validity of patent protection for its products, regulatory developments and its ability to obtain additional funding to support its operations. Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-K for the year ended December 31, 2009, Form 10-Q for the quarter ended September 30, 2010 and Form 8-K filed on October 15, 2010. All forward-looking statements are qualified in their entirety by this cautionary statement. Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

Pegasys® and Copegus® are registered trademarks of Ho
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
6. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
7. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
8. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
11. ANA598 Demonstrates SVR12 in 100% of First Group of HCV Patients Randomized to Stop All Treatment at Week 24
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014 Northwest Biotherapeutics ... company developing DCVax® personalized immune therapies for solid tumor ... product to receive formal designation as a "Promising Innovative ... Scheme" (EAMS) launched in the UK in April 2014. ... process for early access approval under the EAMS.  ...
(Date:9/16/2014)... CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), ... therapeutic products for the prevention and treatment of ... and restatement of its outstanding Series C-2, C-3, ... as well as the warrants issued in its ... remove anti-dilution, price reset and certain change of ...
(Date:9/16/2014)... 16, 2014 Imprimis Pharmaceuticals, Inc. (Nasdaq: ... delivering high quality and novel medicines to physicians and ... Officer Mark Baum will be a presenter ... Conference in New York City.  Mr. Baum will discuss ... campaign in ophthalmology. The presentation is scheduled for 10:40 ...
Breaking Medicine Technology:NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 3NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 4NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 5CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 2Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 3Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 4
... Pharmaceuticals, Inc. (NYSE Amex: INO ), a ... against cancers and infectious diseases, announced today the publication ... Vaccines detailing potent immune responses in a preclinical ... targeting two antigens. While current prostate cancer therapies target ...
... Feb. 1, 2011 Anthera Pharmaceuticals, Inc. (Nasdaq: ... treat serious diseases associated with abnormal auto-immune responses and ... Thompson to its Board of Directors. Currently, Dr. Thompson ... founder and Managing Director of Strategicon Partners, an investment ...
Cached Medicine Technology:Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 2Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 3Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 4Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 5Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors 2
(Date:9/16/2014)... (PRWEB) September 17, 2014 Recently, BamboofloorChina.com, ... added a new assortment of strand woven bamboo ... it has launched a big promotion for the new ... off. , Autumn is a great shopping season. ... items for old and new customers. All practical items ...
(Date:9/16/2014)... A nice seat cover is necessary for those who want ... offered by Lseat.com have every item clients need to completely ... protected from everyday wear and tear. , Today, the ... seat covers and launched an autumn special offer. All ... fabric that is both washable and breathable. That brings a ...
(Date:9/16/2014)... Marybeth Cale, owner of Cale Communications , ... in the small village of Rhinebeck, New York, has announced ... a mompreneur, has expanded the business to incorporate a new ... maximize potential. Those services will include group trainings and workshops ... coaching for clients all over the country. , Workshops ...
(Date:9/16/2014)... Retinol is favored by a majority of dermatologists ... has so many benefits - it is one of those ... Sublime Beauty . "Healthy skin is our goal, and ... Beauty® Retinol Serum with Vitamin C is a non-irritating, silky ... The Retinol Serum with Vitamin C is now ...
(Date:9/16/2014)... 2014 Operation Smile was founded “on the ... a facial deformity.” To spread their message and mission, the ... at the Beverly Wilshire Hotel in Beverly Hills, California. The ... whose lives have been forever transformed by the efforts of ... with Operation Smile,” said Lynda Erkiletian, Executive Director of The ...
Breaking Medicine News(10 mins):Health News:BamboofloorChina.com Announces Its Promotion For Strand Woven Bamboo Floors 2Health News:Lseat.com: 2006-2014 Chevrolet Tahoe Chevrolet Tahoe Leather Seat Covers At Discounted Rates 2Health News:Mompreneur Marybeth Cale of Cale Communications Announces Launch Of Life Coaching And Workshop Business 2Health News:Retinol, the Gold Standard in Skin Care, Available in a Serum with Vitamin C from Sublime Beauty®; Now 30% Off 2Health News:James & Paula Coburn Foundation to Host the 2014 Smile Gala, Presented by Operation Smile 2
... 10-30 minutes a day showed significant improvement in social ... Just 10 minutes to 30 minutes of exercise a ... overweight or obese women, American researchers suggest. , ... who took part in the Dose Response to Exercise ...
... can modestly increase the amount of physical activity among ... the Trial of Activity for Adolescent Girls (TAAG), a ... Heart, Lung, and Blood Institute (NHLBI) of the National ... the article, "Promoting Physical Activity in Middle School Girls," ...
... picture of events that underlie the functions of a ... by Cell Press in the journal Molecular Cell, shows ... clock keeps time and may enhance our understanding of ... , A variety of organisms have evolved endogenous timing ...
... 13 Cuyahoga Community College will,celebrate the grand opening ... from 9 a.m. -- noon at the Western Campus, ... -- 9:45 a.m. in the HTC,and building tours will ... 25,000-square-feet, the new Health Technologies Center,includes four classrooms, six ...
... outreach efforts, experts say , , THURSDAY, March 13 (HealthDay ... warning signs of eye diseases that could blind them ... survey shows. , The telephone survey, released Thursday by ... International Foundation, included interviews conducted with 3,000 adults between ...
... -,Best of Show, award winners and ,New and Notables, announced at the ... Aesthetics ... Conference and Expo-, LOS ANGELES, March 13 An ... Los Angeles Spa & Resort,Expo and Conference and Medical Aesthetics Conference and ...
Cached Medicine News:Health News:Minimal Exercise Benefits Overweight Postmenopausal Women 2Health News:After-school programs can increase physical activity of adolescent girls 2Health News:New research provides dynamic visualization of simplest circadian clock 2Health News:Tri-C to Celebrate Health Technologies Center Grand Opening April 4 2Health News:Survey Finds Many Americans Clueless About Eye Disease 2Health News:'Best of Show' Awards Go to Spa and Medical Aesthetics Industry Stars 2Health News:'Best of Show' Awards Go to Spa and Medical Aesthetics Industry Stars 3Health News:'Best of Show' Awards Go to Spa and Medical Aesthetics Industry Stars 4Health News:'Best of Show' Awards Go to Spa and Medical Aesthetics Industry Stars 5
Castroviejo "HM" Micro Needle Holder with Tungsten-Carbide Inserts, with catch. Serrated....
Curved with catch....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Medium weight bone cutter....
Medicine Products: